News

15 Feb 2021
When will the EU take treatment optimisation seriously?

5 Feb 2021
EORTC embarked on a membership renewal programme

4 Feb 2021
Interview of EORTC members about COVID-19 impact on cancer clinical trials

14 Jan 2021
Webinar: How can current EU policy initiatives pave the way towards treatment optimisation as part of health systems?

17 Dec 2020
EORTC lobbies for reducing the economic burden of cancer by optimising treatment for cancer patients

17 Dec 2020
Pivoting from physical to virtual meetings, engaging with a global audience

17 Dec 2020
The 1553-SPECTA translational research platform registered the 1000th patient

2 Dec 2020
Genito-urinary cancer research looks to the future

30 Nov 2020
European Cancer Summit supports a reorientation of research approaches to address the needs of patients and health systems

18 Nov 2020
15 year follow up of EORTC 22922/10925 phase III trial shows reduction in breast cancer mortality and recurrence but does not confirm improved overall survival

